# Ingevity Corporation Common Stock (NGVT) fundamentals

Data as of 2026-09-08. NYSE, United States. Sector: Basic Materials / Chemicals. Price $70.54, market value $2.4 billion.

## Valuation
- **P/E (trailing): 99.4×** (5-yr avg 18.6×). Ingevity Corporation Common Stock trades at 99.4× trailing earnings, well above its own five-year average of 18.6×: investors are paying up relative to the company's past. The Basic Materials median in the September 2026 study was 19.0×. Forward P/E is 11.7×, lower than trailing, so analysts expect earnings to grow.
- **PEG: 0.19**. A PEG of 0.19 means the P/E is low relative to expected earnings growth: the market is not paying much for that growth.
- **Price / sales: 2.2×**. Each dollar of revenue is priced at 2.2×.
- **Price / book: 51.9×**. The shares trade at 51.9× book value; most of the value is in earnings power and intangibles rather than the balance sheet.
- **Free-cash-flow yield: 6.4%** (5-yr avg 6.9%). Free cash flow equals 6.4% of the market value, in line with its five-year average of 6.9%. Above 5% is generally attractive.
- **Earnings yield: 1.0%**. The inverse of the P/E: 1.0% of the price is earned each year.

## Profitability
- **Gross margin: 41.5%**. Ingevity Corporation Common Stock keeps 41.5% of revenue after the direct cost of what it sells.
- **Net margin: -14.3%**. The company reported a net loss over the last twelve months.
- **Return on equity: -562.6%**. Return on equity is negative because earnings are negative.
- **Return on assets: 3.3%**. Each dollar of assets produces 3.3% of profit.

## Growth
- **Revenue growth (1 yr): -2.7%** (3-yr -11.2%/yr, 5-yr -0.8%/yr). Revenue fell 2.7% over the last year, against -0.8% a year compounded over five years: growth is slowing.
- **EPS growth (1 yr): 61.1%**. Earnings per share rose 61.1%, faster than revenue, so margins expanded or the share count shrank.
- **Free-cash-flow growth (3 yr): 17.0%/yr**. Free cash flow has compounded at 17.0% a year over three years.

## Financial health
- **Debt to equity: 1.59**. Debt is 1.59 times equity, a leveraged balance sheet that needs steady cash flow to service.
- **Altman Z-score: 2.47**. A Z-score of 2.47 is in the grey zone; not distressed, not clearly safe.
- **Piotroski F-score: 6/9**. 6 of 9 checks pass: mixed.

## Dividends
- **Dividend: none**. Ingevity Corporation Common Stock does not currently pay a dividend.

## Analyst view
- **Analyst consensus: strong_buy** (3 analysts). 3 analysts cover Ingevity Corporation Common Stock; the consensus is strong_buy, with an average price target of $89.00 (+26% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): 19.8%** (YTD 19.2%, 3-mo 6.9%). The shares are up 19.8% over twelve months including dividends.
- **From 52-week high: -11.0%** (53.8% above the low). Trading 11% below its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 46**. An RSI of 46 is neutral.
- **Beta (1 yr): 1.13** (volatility 36%). Beta of 1.13 against the S&P 500: the shares move roughly with the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=NGVT · Page: https://foliofundamentals.com/stocks/ngvt

Not investment advice.